跳至主要内容
临床试验/DRKS00024879
DRKS00024879招募中不适用

Immune response and therapy assessment to COVID-19 Vaccinations in people with Diabetes Mellitus – an observational pilot study - COVACDIA

Division Exercise Physiology and Metabolism0 个研究点目标入组 60 人开始时间: 2021年6月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Planned COVID-19 vaccination(Each participant)
  • Cohort I (Diabetes mellitus Type 1, well controlled)
  • Glycated haemoglobin levels HbA1c =7.5 %
  • Cohort II (Diabetes mellitus Type 1, uncontrolled)
  • Glycated haemoglobin levels HbA1c >7.5 %
  • Cohort III (Diabetes mellitus Type 2, well controlled)
  • Glycated haemoglobin levels HbA1c =7.5 %
  • Cohort IV (Diabetes mellitus Type 2, uncontrolled)
  • Glycated haemoglobin levels HbA1c >7.5 %

排除标准

  • Active known malignancy within the last year excluding intraepithelial neoplasia of prostate, gastrointestinal tract and basalioma
  • Pregnancy or intention of becoming pregnant; breastfeeding
  • Immunosuppressive therapy
  • Acute inflammatory disorder
  • Alcohol abuse (more than 15 drinks / week)
  • Any contraindication to the vaccine planned to receive as listed in the product characteristics
  • Previous COVID-19 vaccine or episode of COVID-19
  • / Healthy control group:
  • Presence of disease or therapies that are likely to interfere with the immune response to vaccination
  • Presence of a disease requiring change in therapy during 4 weeks prior to enrollment
  • Any contraindications to the vaccine planned to receive as listed in the product characteristics
  • Women who are pregnant, breastfeeding or not following adequate contraceptive measures
  • Previous vaccination with any coronavirus vaccine or episode of COVID-19

研究者

发起方
Division Exercise Physiology and Metabolism

相似试验

Immune response and therapy assessment to COVID-19... | 临床试验